VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2019 | The TRANSCEND-CLL-004 study: JCAR017

Tanya Siddiqi, MD, from the City of Hope National Medical Center, Duarte, CA, provides updates from the Phase I TRANSCEND-CLL-004 study (NCT03331198) for relapsed/refractory chronic lymphocytic leukemia (CLL). Dr Siddiqi was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter